CSPC Pharmaceuticals Group ADR (CSPCY) – cijena dionice i vijesti

CSPC Pharmaceutical Group researches, develops, manufactures and sells pharmaceutical products. Its headquarters is in China's Hebei Province. CSPC produces both active pharmaceutical ingredient and formulations. API products include penicillin, cefalosporins, synthetic vitamins, caffeine and ranitidine. Formulations include antibiotics, butylphthalide and analgesics, in addition to nearly 1,000 other products. CSPC's 15,000 employees are divided among more than ten subsidiaries, including CSPC Zhongrun, Weisheng, Zhongnuo and NBP. CSPC Pharma's total assets are valued above RMB 8 billion. In 2007, CSPC Pharma achieved sales of RMB 8 billion and net income of RMB 485 million. Direct exports of US$300 million ranked CSPC first among China's pharmaceutical enterprises. One subsidiary, China Pharmaceutical Group Co., Ltd is based in Hong Kong. It is listed on the Hang Seng China-Affiliated Corporations Index. In 2003 and 2004, China Pharma was listed as one of 100 excellent listed companies with turnover less than $1 billion. CSPC Pharma is recognized as one of China's "500 Most Valuable Chinese Brands" and "Top 500 Chinese Enterprises." Wikipedia

CSPC Pharmaceuticals Group ADR – informacije

Glavni izvršni direktorZhang Cuilong

Zaposlenici18,6 tis.

Osnovano1992

Sjedište-

Sektor-

Web-lokacijacspc.com.hk

Sve vrijednosti su u valuti CNY	ruj 2025.	pro 2025.	ožu 2026.	lip 2026.
Prihod	6,62 mlr.	6,11 mlr.	6,47 mlr.	12,13 mlr.
Trošak prodane robe	2,28 mlr.	2,11 mlr.	2,20 mlr.	2,24 mlr.
Trošak prihoda	2,28 mlr.	2,11 mlr.	2,20 mlr.	2,24 mlr.
Izdaci za istraživanje i razvoj	1,50 mlr.	1,62 mlr.	1,40 mlr.	1,63 mlr.
Ukupni izdaci za istraživanje i razvoj	-	-	-	-
Izdaci za prodaju, opći i administrativni izdaci	1,97 mlr.	1,87 mlr.	1,89 mlr.	1,89 mlr.
Poslovni rashod	3,47 mlr.	3,49 mlr.	3,29 mlr.	3,51 mlr.
Ukupni poslovni rashodi	5,75 mlr.	5,60 mlr.	5,49 mlr.	5,75 mlr.
Poslovni prihod	869,63 mil.	514,71 mil.	973,82 mil.	6,38 mlr.
Ostali neposlovni prihod	645,14 mil.	−470,42 mil.	181,80 mil.	11,92 mil.
Zarada prije poreza uključujući neuobičajene stavke	1,18 mlr.	505,59 mil.	1,13 mlr.	6,40 mlr.
Zarada prije poreza isključujući neuobičajene stavke	1,37 mlr.	186,56 mil.	1,13 mlr.	6,35 mlr.
Izdaci za porez na dohodak	222,47 mil.	165,64 mil.	243,25 mil.	825,70 mil.
Efektivna porezna stopa	18,78 %	32,76 %	21,46 %	12,91 %
Ostali poslovni rashodi	-	-	-	-
Neto dohodak	963,54 mil.	370,72 mil.	859,79 mil.	5,23 mlr.
Neto profitna marža	14,56 %	6,06 %	13,30 %	43,16 %
Zarada po dionici	-	-	-	-
Prihod od kamata i ulaganja	-	195,87 mil.	-	91,68 mil.
Izdaci za kamate	−104,94 mil.	−6,76 mil.	−11,01 mil.	−2,30 mil.
Neto izdaci za kamate	−104,94 mil.	189,12 mil.	−11,01 mil.	89,37 mil.
Troškovi amortizacije i otpisa	-	-	-	-
Dobit prije kamata, poreza i amortizacije	1,14 mlr.	802,06 mil.	1,26 mlr.	6,67 mlr.
Dobit ili gubitak od prodaje imovine	-	-	-	-

Pitajte bilo što